Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10154874 Immunotherapeutic methods using irreversible electroporation
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
January 26, 2018
Date of Patent
December 18, 2018
Patent Applicant
Virginia Tech Intellectual Properties
Patent Application Number
15881414
Patent Citations Received
US Patent 12102376 System and method for increasing a target zone for electrical ablation
0
US Patent 11952568 Device and methods for delivery of biphasic electrical pulses for non-thermal ablation
0
US Patent 11974800 Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
0
US Patent 12059197 Blood-brain barrier disruption using reversible or irreversible electroporation
0
US Patent 10292755 High frequency electroporation for cancer therapy
US Patent 10448989 High-frequency electroporation for cancer therapy
US Patent 10471254 Selective modulation of intracellular effects of cells using pulsed electric fields
US Patent 10537379 Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US Patent 10694972 Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
US Patent 10702326 Device and method for electroporation based treatment of stenosis of a tubular body part
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10154874
Patent Primary Examiner
Michael Peffley
Find more entities like US Patent 10154874 Immunotherapeutic methods using irreversible electroporation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE